ストックスクリーナーアプリを入手
8.33
5.23%
-0.46
アフターアワーズ：
7.87
-0.46
-5.52%
前日終値:
$8.79
開ける：
$8.84
24時間の取引高:
935.73K
Relative Volume:
1.16
時価総額：
$801.17M
収益：
$133.62M
当期純損益:
$-177.37M
株価収益率:
-2.8824
EPS:
-2.89
ネットキャッシュフロー:
$23.50M
1週間 パフォーマンス:
-26.02%
1か月 パフォーマンス:
-5.45%
6か月 パフォーマンス:
-64.73%
1年 パフォーマンス:
-64.61%
1日の値動き範囲:
$8.31
$9.37
1週間の範囲:
$7.85
$11.14
52週間の値動き範囲:
$7.16
$27.24
Xencor Inc Stock (XNCR) Company Profile
XNCR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
XNCR
Xencor Inc
|
8.33 | 801.17M | 133.62M | -177.37M | 23.50M | -2.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.99 | 128.84B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
527.78 | 65.38B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
549.65 | 39.67B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
251.15 | 33.82B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
231.99 | 27.60B | 3.81B | -644.79M | -669.77M | -6.24 |
Xencor Inc Stock (XNCR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-21 | 開始されました | William Blair | Outperform |
| 2024-12-12 | 開始されました | Wells Fargo | Overweight |
| 2024-12-02 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2024-04-16 | 繰り返されました | BTIG Research | Buy |
| 2024-02-28 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2023-05-19 | 開始されました | BofA Securities | Buy |
| 2022-12-06 | 開始されました | Cowen | Outperform |
| 2022-10-13 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2022-09-21 | 開始されました | JP Morgan | Overweight |
| 2022-07-06 | 再開されました | Canaccord Genuity | Buy |
| 2022-02-11 | 開始されました | BMO Capital Markets | Outperform |
| 2022-01-21 | 開始されました | SMBC Nikko | Outperform |
| 2021-12-15 | 開始されました | H.C. Wainwright | Buy |
| 2021-10-15 | 再開されました | BTIG Research | Buy |
| 2021-02-24 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2020-03-04 | 開始されました | Barclays | Underweight |
| 2020-02-25 | アップグレード | Guggenheim | Neutral → Buy |
| 2020-01-30 | 開始されました | RBC Capital Mkts | Outperform |
| 2019-11-20 | 再開されました | Guggenheim | Neutral |
| 2019-08-07 | ダウングレード | Guggenheim | Buy → Neutral |
| 2019-08-07 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2019-06-13 | 開始されました | Mizuho | Buy |
| 2019-04-12 | 開始されました | Guggenheim | Buy |
| 2019-03-27 | 開始されました | Berenberg | Buy |
| 2019-03-15 | 開始されました | Raymond James | Outperform |
| 2018-09-10 | 再開されました | BTIG Research | Buy |
| 2018-03-28 | 再開されました | Leerink Partners | Outperform |
| 2017-03-02 | 開始されました | Instinet | Neutral |
| 2017-03-02 | 繰り返されました | Wedbush | Outperform |
| 2016-10-04 | 開始されました | Piper Jaffray | Overweight |
| 2015-12-22 | 開始されました | Canaccord Genuity | Buy |
| 2015-08-05 | 繰り返されました | MLV & Co | Buy |
| 2015-02-12 | 繰り返されました | Oppenheimer | Outperform |
| 2015-01-28 | 繰り返されました | MLV & Co | Buy |
| 2014-07-11 | 開始されました | Oppenheimer | Outperform |
すべてを表示
Xencor Inc (XNCR) 最新ニュース
Barclays Issues Pessimistic Forecast for Xencor (NASDAQ:XNCR) Stock Price - Defense World
JPMorgan cuts Xencor stock price target to $20, keeps overweight rating - Investing.com Australia
Xencor Inc earnings missed by $0.04, revenue topped estimates - Investing.com Nigeria
Xencor (XNCR) Analyst Rating Update: Price Target Slashed by Bar - GuruFocus
Xencor (XNCR) Analyst Rating Update: Price Target Slashed by Barclays | XNCR Stock News - GuruFocus
JPMorgan cuts Xencor stock price target to $20, keeps overweight rating By Investing.com - Investing.com South Africa
Xencor Reports First Quarter 2025 Financial Results - BioSpace
Xencor: Q1 Earnings Snapshot - MySA
Xencor (XNCR) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
(XNCR) Technical Data - news.stocktradersdaily.com
Xencor (NASDAQ:XNCR) Earns Outperform Rating from Wedbush - Defense World
Healthy Upside Potential: Xencor Inc (XNCR) - Sete News
Xencor reports positive trial results for inflammatory bowel disease treatment - MSN
Will Xencor (XNCR) Report Negative Q1 Earnings? What You Should Know - Yahoo Finance
Wells Fargo & Company MN Raises Stock Holdings in Xencor, Inc. (NASDAQ:XNCR) - Defense World
Analyzing Xencor Inc (XNCR) After Recent Trading Activity - knoxdaily.com
Trading Day Triumph: Xencor Inc (XNCR) Ends at 10.58, a -0.19 Surge/Plunge - DWinneX
Is Xencor Inc (XNCR) a good investment opportunity? - uspostnews.com
Xencor Announces Promising Phase 1 Study Results - TipRanks
Raymond James Financial Inc. Invests $2.33 Million in Xencor, Inc. (NASDAQ:XNCR) - Defense World
Xencor (XNCR) Reports Promising Results and Advances XmAb942 Stu - GuruFocus
Xencor Announces Positive Interim Results From First-in-Human Healthy Volunteer Study of XmAb942, a High-Potency Extended Half-Life Anti-TL1A Antibody, in Development for Treatment of Inflammatory Bowel Disease - BioSpace
Xencor posts trial data for bowel disease drug (XNCR:NASDAQ) - Seeking Alpha
Xencor advances ulcerative colitis treatment into Phase 2b study - Investing.com
Xencor (XNCR) Reports Promising Results and Advances XmAb942 Study | XNCR Stock News - GuruFocus
Press Release Distribution & PR Platform - ACCESS Newswire
Is Xencor (NASDAQ:XNCR) A Risky Investment? - simplywall.st
LPL Financial LLC Has $452,000 Position in Xencor, Inc. (NASDAQ:XNCR) - Defense World
Gaining Ground: Xencor Inc (XNCR) Closes Higher at 10.87, Up 2.07 - DWinneX
It is Poised to be a Bull Market for Xencor Inc (XNCR) - Sete News
Equities Analysts Issue Forecasts for Xencor Q1 Earnings - Defense World
Is the Xencor Inc (NASDAQ:XNCR) stock an investment opportunity? - uspostnews.com
Invesco Ltd. Sells 156,130 Shares of Xencor, Inc. (NASDAQ:XNCR) - Defense World
JPMorgan Chase & Co. Sells 9,291 Shares of Xencor, Inc. (NASDAQ:XNCR) - Defense World
Xencor Inc Shares Are Up -44.42% Since The Beginning Of The Year - Marketing Sentinel
Xencor Inc (XNCR) Stock: A Year of Stock Market Ups and Downs - investchronicle.com
Xencor (NASDAQ:XNCR) Now Covered by Analysts at William Blair - Defense World
William Blair Initiates Coverage of Xencor (XNCR) with Outperform Recommendation - Nasdaq
William Blair starts Xencor stock with Outperform rating By Investing.com - Investing.com Canada
Xencor Reports Fourth Quarter and Full Year 2024 Financial Results - ADVFN
Xencor (XNCR) Receives Outperform Rating from William Blair | XN - GuruFocus
William Blair starts Xencor stock with Outperform rating - Investing.com
Xencor, Inc. (NASDAQ:XNCR) Given Consensus Rating of “Buy” by Analysts - Defense World
Xencor, Inc. (NASDAQ:XNCR) Shares Sold by Alliancebernstein L.P. - Defense World
Geode Capital Management LLC Acquires 179,526 Shares of Xencor, Inc. (NASDAQ:XNCR) - Defense World
Wellington Management Group LLP Purchases Shares of 27,491 Xencor, Inc. (NASDAQ:XNCR) - The AM Reporter
27,491 Shares in Xencor, Inc. (NASDAQ:XNCR) Acquired by Wellington Management Group LLP - Defense World
Xencor Inc (XNCR) 財務データ
収益
当期純利益
現金流量
EPS
0.84%
0.15%
大文字化:
|
ボリューム (24 時間):